CA2651934A1 - Mass spectrometry biomarker assay - Google Patents

Mass spectrometry biomarker assay Download PDF

Info

Publication number
CA2651934A1
CA2651934A1 CA002651934A CA2651934A CA2651934A1 CA 2651934 A1 CA2651934 A1 CA 2651934A1 CA 002651934 A CA002651934 A CA 002651934A CA 2651934 A CA2651934 A CA 2651934A CA 2651934 A1 CA2651934 A1 CA 2651934A1
Authority
CA
Canada
Prior art keywords
biomarker
sample
signal
mass
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002651934A
Other languages
English (en)
French (fr)
Inventor
Toshihide Nishimura
Atsushi Ogiwara
Takeshi Kawamura
Takao Kawakami
Yutaka Kyono
Mitsuhiro Kanazawa
Fredrik Nyberg
Gyoergy Marko-Varga
Hisase Anyoji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Medical Proteoscope Co Ltd
Original Assignee
Astrazeneca Uk Limited
Toshihide Nishimura
Atsushi Ogiwara
Takeshi Kawamura
Takao Kawakami
Yutaka Kyono
Mitsuhiro Kanazawa
Fredrik Nyberg
Gyoergy Marko-Varga
Hisase Anyoji
Medical Proteoscope Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited, Toshihide Nishimura, Atsushi Ogiwara, Takeshi Kawamura, Takao Kawakami, Yutaka Kyono, Mitsuhiro Kanazawa, Fredrik Nyberg, Gyoergy Marko-Varga, Hisase Anyoji, Medical Proteoscope Co Ltd filed Critical Astrazeneca Uk Limited
Publication of CA2651934A1 publication Critical patent/CA2651934A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/74—Optical detectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CA002651934A 2006-06-13 2007-06-13 Mass spectrometry biomarker assay Abandoned CA2651934A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0611669.3A GB0611669D0 (en) 2006-06-13 2006-06-13 Mass spectrometry biomarker assay
GB0611669.3 2006-06-13
PCT/GB2007/002187 WO2007144606A2 (en) 2006-06-13 2007-06-13 Mass spectrometry biomarker assay

Publications (1)

Publication Number Publication Date
CA2651934A1 true CA2651934A1 (en) 2007-12-21

Family

ID=36745797

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002651934A Abandoned CA2651934A1 (en) 2006-06-13 2007-06-13 Mass spectrometry biomarker assay

Country Status (10)

Country Link
EP (1) EP2035829A2 (es)
JP (1) JP2009540319A (es)
KR (1) KR20090068199A (es)
CN (1) CN101611313A (es)
AU (1) AU2007258970A1 (es)
BR (1) BRPI0711967A2 (es)
CA (1) CA2651934A1 (es)
GB (1) GB0611669D0 (es)
MX (1) MX2008015158A (es)
WO (1) WO2007144606A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2304421A4 (en) * 2008-07-23 2017-05-31 P Devices Inc. Portable plasma based diagnostic apparatus and diagnostic method
GB0906698D0 (en) 2009-04-17 2009-06-03 Queen Mary & Westfield College Method for quantifying modified peptides
KR101144237B1 (ko) * 2009-12-29 2012-05-11 한국기초과학지원연구원 고분해능 질량분석법과 약리활성검사를 이용한 천연물의 약리 활성물질 발굴 방법
GB201006360D0 (en) * 2010-04-16 2010-06-02 Immatics Biotechnologies Gmbh Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
CN102201039A (zh) * 2010-08-19 2011-09-28 上海聚类生物科技有限公司 一种分析ltq数据的方法
GB201204278D0 (en) 2012-03-09 2012-04-25 Queen Mary & Westfield College Method
FR3016461B1 (fr) * 2014-01-10 2017-06-23 Imabiotech Procede de traitement de donnees d'imagerie moleculaire et serveur de donnees correspondant
DE102014000646B4 (de) 2014-01-17 2023-05-11 Bruker Daltonics GmbH & Co. KG Massenspektrometrische Resistenzbestimmung durch Metabolismus-Messung
GB201509313D0 (en) * 2015-05-29 2015-07-15 Micromass Ltd Sample mass spectrum analysis
US11435354B2 (en) * 2016-02-19 2022-09-06 University Of Miyazaki Adenocarcinoma detection method
US20190113520A1 (en) * 2016-03-31 2019-04-18 Discerndx, Inc. Biomarker Database Generation and Use
ES2877368T3 (es) * 2016-05-24 2021-11-16 In Ovo Holding B V Método y sistema para la determinación in ovo no destructiva del género de las aves
US20190187048A1 (en) * 2016-08-19 2019-06-20 Monash University Spectroscopic systems and methods for the identification and quantification of pathogens
US9905405B1 (en) * 2017-02-13 2018-02-27 Thermo Finnigan Llc Method of generating an inclusion list for targeted mass spectrometric analysis
SG11201908865WA (en) * 2017-06-29 2019-10-30 Quanticision Diagnostics Inc Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis
CN111148844A (zh) 2017-09-01 2020-05-12 韦恩生物科技股份公司 鉴定和使用糖肽作为诊断和治疗监测的生物标记物
EP3679378A2 (en) * 2017-09-05 2020-07-15 DiscernDx, Inc. Automated sample workflow gating and data analysis
GB2569805B (en) * 2017-12-22 2023-03-08 Asymptote Ltd Method and system relating to cooling conditions for a biological sample
EP3794548A1 (en) * 2018-05-15 2021-03-24 Ventana Medical Systems, Inc. Quantitation of signal in stain aggregates
CN111672658B (zh) * 2020-06-08 2022-05-13 惠州市新泓威科技有限公司 电子雾化设备最佳雾化温度的检测与控制方法及其电子雾化设备
EP4047371A1 (en) * 2021-02-18 2022-08-24 Thermo Fisher Scientific (Bremen) GmbH Method and apparatus for analysing samples of biomolecules using mass spectrometry with data-independent acquisition
KR102632163B1 (ko) 2022-04-13 2024-02-01 오보젠 주식회사 가금류 알(卵)의 암수 검사 및 선별장치 그리고 이를 이용한 선별방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8014952B2 (en) * 2002-12-18 2011-09-06 Queen Elizabeth Hospital Serum biomarkers in lung cancer
DE10324149A1 (de) * 2003-05-26 2004-12-16 Imat-Uve Gmbh Verfahren und Vorrichtung zur GC/MS- oder LC/MS-Screeninganalyse
JP2007531879A (ja) * 2004-03-30 2007-11-08 イースタン バージニア メディカル スクール 肺癌バイオマーカー
DE112005001166B4 (de) * 2004-05-20 2014-10-09 Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) Verfahren und Vorrichtung zum Identifizieren von Proteinen in Gemischen

Also Published As

Publication number Publication date
EP2035829A2 (en) 2009-03-18
AU2007258970A1 (en) 2007-12-21
JP2009540319A (ja) 2009-11-19
KR20090068199A (ko) 2009-06-25
WO2007144606A3 (en) 2008-04-03
BRPI0711967A2 (pt) 2012-01-24
CN101611313A (zh) 2009-12-23
GB0611669D0 (en) 2006-07-19
WO2007144606A2 (en) 2007-12-21
MX2008015158A (es) 2009-04-30

Similar Documents

Publication Publication Date Title
CA2651934A1 (en) Mass spectrometry biomarker assay
Angel et al. Mass spectrometry-based proteomics: existing capabilities and future directions
US7538321B2 (en) Method of identifying substances using mass spectrometry
JP4932834B2 (ja) 保持時間整合を行うための方法および装置
EP2279260B1 (en) Techniques for performing retention-time matching of precursor and product ions and for constructing precursor and product ion spectra
US20100233815A1 (en) Methods for the Development of a Biomolecule Assay
WO2003042774A2 (en) Mass intensity profiling system and uses thereof
EP1886134A1 (en) Methods and apparatus for fractionation-based chemical analyses
US7070949B2 (en) Protein mixture analysis by mass spectrometry
Sokolowska et al. Applications of mass spectrometry in proteomics
Fuller et al. Quantitative proteomics using iTRAQ labeling and mass spectrometry
EP1887351A1 (en) Screening method for specific protein in proteome comprehensive analysis
Masselon et al. Identification of tryptic peptides from large databases using multiplexed tandem mass spectrometry: simulations and experimental results
Hall et al. Isotope-differentiated binding energy shift tags (IDBEST™) for improved targeted biomarker discovery and validation
Merkley et al. A proteomics tutorial
WO2005057208A1 (en) Methods of identifying peptides and proteins
CN112630344B (zh) 代谢标志物在脑梗死中的用途
Vaezzadeh et al. Proteomics and opportunities for clinical translation in urological disease
Henry et al. Introduction to sample preparation for proteomics and mass spectrometry
Meyers et al. Protein identification and profiling with mass spectrometry.
ÜNAL Mass Spectrometry in Clinical Diagnosis: Cancer Biomarkers
Hathout et al. Current Proteome Profiling Methods
JPWO2007072648A1 (ja) 質量分析システムおよび質量分析方法
Conrads et al. Mass Spectrometry‐Based Proteomic Approaches for Disease Diagnosis and Biomarker Discovery
De Wit et al. The application of proteomics to fetal and maternal medicine

Legal Events

Date Code Title Description
FZDE Discontinued